Skip to content

Discrete Hypothermia in the Management of Traumatic Brain Injury

Discrete Hypothermia in the Management of Traumatic Brain Injury

Status
Completed
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00676104
Enrollment
25
Registered
2008-05-12
Start date
2006-07-31
Completion date
2008-10-31
Last updated
2013-12-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Severe Traumatic Brain Injury

Keywords

Traumatic Brain Injury, Trauma, Hypothermia

Brief summary

The primary goal of this project is to demonstrate the feasibility and clinical benefits of a new rapid treatment for secondary treatment for secondary brain injury called Discrete Cerebral Hypothermia System by CoolSystems, Inc., Berkley, CA. This device induced hypothermia in the adult brain without significant whole body hypothermia. Discrete Cerebral Hypothermia System holds a great potential for protecting the brain from the devastating secondary complications of trauma without the associated deleterious system effects.

Interventions

DEVICECoolSystems Discrete Cerebral Hypothermia System

The CoolSystems Discrete Cerebral Hypothermia System (DCHS) will be removed from the patients head after 48 hours.

Sponsors

Emory University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
FACTORIAL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patient is treated for severe traumatic brain injury at Grady Health System, GCS \< 8 * Patient is \>18 years of age * Patient requires an Intracranial Pressure (ICP) Probe (part of their routine treatment) * Patient is able to receive Discrete Cerebral Hypothermia within 48-hours of hospital admission * Patient and/or guardian must speak English (in order to ensure proper Informed Consent) * Patient and/or guardian/family must sign an Informed Consent

Exclusion criteria

* Unwillingness or inability of patient and/or guardian/ family to sign an informed consent * Physical placement of cooling cap impedes routine treatment * Patient has a core body temperature of 36 degrees C or less at time of assessment

Design outcomes

Primary

MeasureTime frame
Perform a comparative analysis of outcome (Glasgow Outcome Score)Day 1, day 2, day 3, day 7, day 14, day 21, day 28 and 1 month after injury

Secondary

MeasureTime frame
The effectiveness of the Discrete Cerebral Hypothermia System by CoolSystems in maintaining a significant gradient between the core and brain temperatures in study population.within 3 days after injury
Functional Independence MeasureDay 1, day 2, day 3, day 7, day 14, day 21, day 28 and 1 month after injury
MortalityDay 1, day 2, day 3, day 7, day 14, day 21, day 28 and 1 month after injury
Confirm the effectiveness of the Discrete Cerebral System in reducing internal brain temperaturewithin 3 days after injury

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026